Na-Teng Hung1, Vivek Paul1, Prashanth Prakash1, Torin Kovach1, Gene Tacy2, Goran Tomic1, Sangsoo Park1, Tyler Jacobson1, Alix Jampol3, Pooja Patel3, Anya Chappel3, Erin King3, Marc W Slutzky1,4,5,6. 1. Department of Neurology, Northwestern University, Chicago, Illinois, 60611, USA. 2. Myomo, Inc., Cambridge, Massachusetts, 02142, USA. 3. Department of Occupational Therapy, Northwestern Medicine, Chicago, Illinois, 60611, USA. 4. Departments of Physiology, Northwestern University, Chicago, Illinois, 60611, USA. 5. Departments of Physical Medicine and Rehabilitation, Northwestern University, Chicago, Illinois, 60611, USA. 6. Departments of Biomedical Engineering, Northwestern University, Chicago, Illinois, 60611, USA.
Abstract
BACKGROUND: High-intensity occupational therapy can improve arm function after stroke, but many people lack access to such therapy. Home-based therapies could address this need, but they don't typically address abnormal muscle co-activation, an important aspect of arm impairment. An earlier study using lab-based, myoelectric computer interface game training enabled chronic stroke survivors to reduce abnormal co-activation and improve arm function. Here, we assess feasibility of doing this training at home using a novel, wearable, myoelectric interface for neurorehabilitation training (MINT) paradigm. OBJECTIVE: Assess tolerability and feasibility of home-based, high-dose MINT therapy in severely impaired chronic stroke survivors. METHODS: Twenty-three participants were instructed to train with the MINT and game for 90 min/day, 36 days over 6 weeks. We assessed feasibility using amount of time trained and game performance. We assessed tolerability (enjoyment and effort) using a customized version of the Intrinsic Motivation Inventory at the conclusion of training. RESULTS: Participants displayed high adherence to near-daily therapy at home (mean of 82 min/day of training; 96% trained at least 60 min/day) and enjoyed the therapy. Training performance improved and co-activation decreased with training. Although a substantial number of participants stopped training, most dropouts were due to reasons unrelated to the training paradigm itself. INTERPRETATION: Home-based therapy with MINT is feasible and tolerable in severely impaired stroke survivors. This affordable, enjoyable, and mobile health paradigm has potential to improve recovery from stroke in a variety of settings. Clinicaltrials.gov: NCT03401762.
BACKGROUND: High-intensity occupational therapy can improve arm function after stroke, but many people lack access to such therapy. Home-based therapies could address this need, but they don't typically address abnormal muscle co-activation, an important aspect of arm impairment. An earlier study using lab-based, myoelectric computer interface game training enabled chronic stroke survivors to reduce abnormal co-activation and improve arm function. Here, we assess feasibility of doing this training at home using a novel, wearable, myoelectric interface for neurorehabilitation training (MINT) paradigm. OBJECTIVE: Assess tolerability and feasibility of home-based, high-dose MINT therapy in severely impaired chronic stroke survivors. METHODS: Twenty-three participants were instructed to train with the MINT and game for 90 min/day, 36 days over 6 weeks. We assessed feasibility using amount of time trained and game performance. We assessed tolerability (enjoyment and effort) using a customized version of the Intrinsic Motivation Inventory at the conclusion of training. RESULTS: Participants displayed high adherence to near-daily therapy at home (mean of 82 min/day of training; 96% trained at least 60 min/day) and enjoyed the therapy. Training performance improved and co-activation decreased with training. Although a substantial number of participants stopped training, most dropouts were due to reasons unrelated to the training paradigm itself. INTERPRETATION: Home-based therapy with MINT is feasible and tolerable in severely impaired stroke survivors. This affordable, enjoyable, and mobile health paradigm has potential to improve recovery from stroke in a variety of settings. Clinicaltrials.gov: NCT03401762.
Authors: Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao Journal: Circulation Date: 2020-01-29 Impact factor: 29.690
Authors: Pamela W Duncan; Ronnie D Horner; Dean M Reker; Gregory P Samsa; Helen Hoenig; Byron Hamilton; Barbara J LaClair; Tara K Dudley Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: Carolee J Winstein; Dorian K Rose; Sylvia M Tan; Rebecca Lewthwaite; Helena C Chui; Stanley P Azen Journal: Arch Phys Med Rehabil Date: 2004-04 Impact factor: 3.966
Authors: Catherine E Lang; Jillian R Macdonald; Darcy S Reisman; Lara Boyd; Teresa Jacobson Kimberley; Sheila M Schindler-Ivens; T George Hornby; Sandy A Ross; Patricia L Scheets Journal: Arch Phys Med Rehabil Date: 2009-10 Impact factor: 3.966
Authors: Elizabeth J Woytowicz; Jeremy C Rietschel; Ronald N Goodman; Susan S Conroy; John D Sorkin; Jill Whitall; Sandy McCombe Waller Journal: Arch Phys Med Rehabil Date: 2016-08-09 Impact factor: 3.966